Literature DB >> 3918115

The expression of major histocompatibility antigens under metallothionein gene promoter control.

J H Weis, J G Seidman.   

Abstract

A model system has been developed that provides insights into the mechanisms that control the amount of H-2 antigen on the cell surface. Hybrid genes have been constructed by using the metallothionein gene promoter to replace the H-2 gene promoter. The hybrid genes have been introduced into murine L cells and their expression has been studied. Cells containing the hybrid genes contain 20- to 60-fold more H-2 mRNA than nontransfected L cells, since the metallothionein gene promoter is much more active than the H-2 promoter. However, the total amount of H-2 antigen on the surface of the transfected L cell is similar to the amount of H-2 antigen on the normal L cell. Even after transcription from the metallothionein promoter is induced by the addition of cadmium to the cell culture medium, the amount of H-2 antigen on the surface of cells containing the hybrid genes does not increase. We conclude that the amount of H-2 antigen is controlled by events that occur after gene transcription. Evidence is presented that suggests that these post-transcriptional mechanisms may cause the expression of threefold more H-2Dd than H-2Ld on the surface of BALB/c cells. Furthermore, we suggest that the 5' untranslated portion of the H-2 mRNA is not important for directing the growing H-2 polypeptide to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918115

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.

Authors:  M K Hart; K J Weinhold; R M Scearce; E M Washburn; C A Clark; T J Palker; B F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  H-2Ld antigen encoded by a recombinant retrovirus genome is expressed on the surface of infected cells.

Authors:  J H Weis; C S Reiss; R C Mulligan; S J Burakoff; J G Seidman
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

3.  Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells.

Authors:  Y Shimizu; B Koller; D Geraghty; H Orr; S Shaw; P Kavathas; R DeMars
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

4.  Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells.

Authors:  H M Friedman; A Yee; H Diggelmann; J C Hastings; R Tal-Singer; C A Seidel-Dugan; R J Eisenberg; G H Cohen
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

5.  Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.

Authors:  E Shiloni; S E Karp; M C Custer; J Shilyansky; N P Restifo; S A Rosenberg; J J Mulé
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

6.  Control of synthesis and expression of H-2 heavy chain and beta-2 microglobulin in AKR leukemias.

Authors:  W Schmidt; U Henseling; D Bevec; A D Alonzo; H Festenstein
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  Three distinct signals can induce class II gene expression in a murine pre-B-cell line.

Authors:  B S Polla; A Poljak; S G Geier; S G Nathenson; J Ohara; W E Paul; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Identification of human cancers deficient in antigen processing.

Authors:  N P Restifo; F Esquivel; Y Kawakami; J W Yewdell; J J Mulé; S A Rosenberg; J R Bennink
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

9.  Hormonal regulation of cell surface expression of the major histocompatibility antigen H-2Ld in transfected cells.

Authors:  H Ponta; R Ball; M Steinmetz; B Groner
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

10.  Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.

Authors:  R Rotem-Yehudar; S Winograd; S Sela; J E Coligan; R Ehrlich
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.